Literature DB >> 21067317

Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood.

Katharina M Iwaniuk1, Jessica Schira, Sandra Weinhold, Marc Jung, James Adjaye, Hans Werner Müller, Peter Wernet, Hans-Ingo Trompeter.   

Abstract

Unrestricted somatic stem cells (USSCs) represent an intrinsically multipotent CD45-negative fetal population from human cord blood. They show differentiation into neuronal cells of a dopaminergic phenotype, which express neuronal markers such as synaptophysin, neuronal-specific nuclear protein, and neurofilament and release the neurotransmitter dopamine accompanied by expression of dopaminergic key factors tyrosine hydroxylase and Nurr1 (NR4A2). MicroRNA expression analysis highlighted their importance in neural development but their specific functions remain poorly understood. Here, downregulation of a set of 18 microRNAs during neuronal lineage differentiation of unrestricted somatic stem cells, including members of the miR-17-92 family and additional microRNAs such as miR-130a, -138, -218, and -335 as well as their target genes, is described. In silico target gene predictions for this microRNA group uncovered a large set of proteins involved in neuronal differentiation and having a strong impact on differentiation-related pathways such as axon guidance and TGFβ, WNT, and MAPK signaling. Experimental target validations confirmed approximately 35% of predictions tested and revealed a group of proteins with specific impact on neuronal differentiation and function including neurobeachin, neurogenic differentiation 1, cysteine-rich motor neuron protein 1, neuropentraxin 1, and others. These proteins are combined targets for several subgroups from the set of 18 downregulated microRNAs. This finding was further supported by the observed upregulation of a significant amount of predicted and validated target genes based on Illumina Beadstudio microarray data. Confirming the functional relationship of a limited panel of microRNAs and predicted target proteins reveals a clear network-like impact of the group of 18 downregulated microRNAs on proteins involved in neuronal development and function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21067317     DOI: 10.1089/scd.2010.0341

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  9 in total

1.  Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility.

Authors:  Dana Ziliak; Eric R Gamazon; Bonnie Lacroix; Hae Kyung Im; Yujia Wen; Rong Stephanie Huang
Journal:  Mol Cancer Ther       Date:  2012-06-29       Impact factor: 6.261

2.  G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Authors:  Danielle M Hsu; Saurabh Agarwal; Ashley Benham; Cristian Coarfa; Denae N Trahan; Zaowen Chen; Paris N Stowers; Amy N Courtney; Anna Lakoma; Eveline Barbieri; Leonid S Metelitsa; Preethi Gunaratne; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2013-05-16       Impact factor: 12.701

3.  MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood.

Authors:  Hans-Ingo Trompeter; Janine Dreesen; Eugenie Hermann; Katharina M Iwaniuk; Markus Hafner; Neil Renwick; Thomas Tuschl; Peter Wernet
Journal:  BMC Genomics       Date:  2013-02-19       Impact factor: 3.969

4.  MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC.

Authors:  Hans-Ingo Trompeter; Hassane Abbad; Katharina M Iwaniuk; Markus Hafner; Neil Renwick; Thomas Tuschl; Jessica Schira; Hans Werner Müller; Peter Wernet
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

5.  Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha.

Authors:  Nina Graffmann; Sarah Ring; Marie-Ann Kawala; Wasco Wruck; Audrey Ncube; Hans-Ingo Trompeter; James Adjaye
Journal:  Stem Cells Dev       Date:  2016-07-15       Impact factor: 3.272

6.  Human Cord Blood-Derived Unrestricted Somatic Stem Cell Infusion Improves Neurobehavioral Outcome in a Rabbit Model of Intraventricular Hemorrhage.

Authors:  Govindaiah Vinukonda; Yanling Liao; Furong Hu; Larisa Ivanova; Deepti Purohit; Dina A Finkel; Priyadarshani Giri; Lakshmipramoda Bapatla; Shetal Shah; Muhammed T Zia; Karen Hussein; Mitchell S Cairo; Edmund F La Gamma
Journal:  Stem Cells Transl Med       Date:  2019-07-19       Impact factor: 6.940

7.  A systemic transcriptome analysis reveals the regulation of neural stem cell maintenance by an E2F1-miRNA feedback loop.

Authors:  Thomas Palm; Kathrin Hemmer; Julia Winter; Inga B Fricke; Katsiaryna Tarbashevich; Fereshteh Sadeghi Shakib; Ina-Maria Rudolph; Anna-Lena Hillje; Paola De Luca; Lamia'a Bahnassawy; Rabea Madel; Thomas Viel; Adriana De Siervi; Andreas H Jacobs; Sven Diederichs; Jens C Schwamborn
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

8.  Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.

Authors:  Barbara Kramarz; Rachael P Huntley; Milagros Rodríguez-López; Paola Roncaglia; Shirin C C Saverimuttu; Helen Parkinson; Rina Bandopadhyay; Maria-Jesus Martin; Sandra Orchard; Nigel M Hooper; David Brough; Ruth C Lovering
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Functional omics analyses reveal only minor effects of microRNAs on human somatic stem cell differentiation.

Authors:  Jessica Schira-Heinen; Agathe Czapla; Marion Hendricks; Andreas Kloetgen; Wasco Wruck; James Adjaye; Gesine Kögler; Hans Werner Müller; Kai Stühler; Hans-Ingo Trompeter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.